Beryl Drugs Ltd. | Balance Sheet
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,439.70
8,178.00
6,316.40
7,653.50
3,101.00
Total Accounts Receivable
25,619.10
36,505.90
35,970.60
35,953.80
47,809.00
Inventories
14,062.50
15,027.90
15,422.60
26,899.10
12,539.00
Other Current Assets
7,237.80
4,439.00
2,028.50
2,938.90
12,334.00
Total Current Assets
49,359.10
64,150.80
59,738.00
73,445.30
75,783.00
Net Property, Plant & Equipment
29,237.50
26,632.50
24,399.70
23,217.80
22,883.00
Total Investments and Advances
6,784.00
7,745.80
6,784.00
6,784.00
2,171.00
Long-Term Note Receivable
-
-
581.20
581.20
-
Intangible Assets
5.10
40.00
43.40
62.40
62.00
Other Assets
11,253.30
8,574.40
7,503.60
6,588.60
6,514.00
Total Assets
97,903.30
109,175.40
101,492.10
113,460.00
110,856.00
ST Debt & Current Portion LT Debt
15,364.50
16,994.60
16,946.90
16,185.80
13,865.00
Accounts Payable
13,468.80
22,160.60
7,428.30
11,559.10
14,149.00
Income Tax Payable
2,154.00
937.00
846.70
1,914.50
-
Other Current Liabilities
1,217.00
2,027.40
7,435.40
12,773.00
12,047.00
Total Current Liabilities
32,204.40
42,119.60
32,657.30
42,432.40
40,061.00
Long-Term Debt
-
223.00
35.30
947.60
732.00
Provision for Risks & Charges
1,494.30
1,877.50
2,178.80
2,134.80
1,875.00
Deferred Taxes
1,264.20
2,031.80
2,442.10
2,780.60
3,443.00
Total Liabilities
33,698.60
44,220.10
34,871.30
45,514.80
42,668.00
Common Equity (Total)
63,725.90
64,476.50
66,142.10
67,466.40
68,188.00
Total Shareholders' Equity
63,725.90
64,476.50
66,142.10
67,466.40
68,188.00
Total Equity
63,725.90
64,476.50
66,142.10
67,466.40
68,188.00
Liabilities & Shareholders' Equity
97,903.30
109,175.40
101,492.10
113,460.00
110,856.00
Non-Equity Reserves
478.70
478.70
478.70
478.70
-
About Beryl Drugs
View Profile
